The Patent Finder

Lineage Cell Therapeutics, Inc.

Also on record
Records under this name other than the patents Lineage Cell Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Lineage Cell Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,961,531Compositions and methods for induced tissue regeneration in mammalian species
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,421,513Compositions and methods for induced tissue regeneration in mammalian species
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,492,400Compositions and methods for induced tissue regeneration in mammalian species
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,404,493Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 12,365,872Methods for Differentiating Pluripotent Stem Cells in Dynamic Suspension Culture
Held by another company
In force
 · High confidence
In forceHigh confidence
US 8,685,386Methods and compositions for in vitro and in vivo chondrogenesis
Lapsed on the fee record
Ended Apr 1, 2026 · USPTO record
Lapsed on the fee recordEnded Apr 1, 2026USPTO record
US 9,732,128Methods of modifying transcriptional regulatory networks in stem cells
Lapsed on the fee record
Ended Aug 15, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 15, 2025USPTO record
US 10,920,191Methods of screening embryonic progenitor cell lines
Lapsed on the fee record
Ended Feb 16, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 16, 2025USPTO record
US 10,865,383Methods and formulations for orthopedic cell therapy
Lapsed on the fee record
Ended Dec 15, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 15, 2024USPTO record
US 9,175,263Methods and compositions for targeting progenitor cell lines
Lapsed on the fee record
Ended Nov 3, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 3, 2023USPTO record
10 of 36 patents shown.
Pro members see all 36.
Pro members: see all 36 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited